fasudil has been researched along with Anterior Ischemic Optic Neuropathy in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study evaluated the effects of intravitreal injection of fasudil (IVF), a Rho-kinase inhibitor, in cases of recent-onset nonarteritic anterior ischemic optic neuropathy (NAION)." | 7.83 | Intravitreal Injection of a Rho-Kinase Inhibitor (Fasudil) for Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy. ( Ahmadieh, H; Esfandiari, H; Hafezi-Moghadam, A; Jamali, A; Nakao, S; Nourinia, R; Pakravan, M; Sanjari, N; Shah-Heidari, MH; Yaseri, M; Zandi, S, 2016) |
| "This study evaluated the effects of intravitreal injection of fasudil (IVF), a Rho-kinase inhibitor, in cases of recent-onset nonarteritic anterior ischemic optic neuropathy (NAION)." | 3.83 | Intravitreal Injection of a Rho-Kinase Inhibitor (Fasudil) for Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy. ( Ahmadieh, H; Esfandiari, H; Hafezi-Moghadam, A; Jamali, A; Nakao, S; Nourinia, R; Pakravan, M; Sanjari, N; Shah-Heidari, MH; Yaseri, M; Zandi, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sanjari, N | 1 |
| Pakravan, M | 1 |
| Nourinia, R | 1 |
| Esfandiari, H | 1 |
| Hafezi-Moghadam, A | 1 |
| Zandi, S | 1 |
| Nakao, S | 1 |
| Shah-Heidari, MH | 1 |
| Jamali, A | 1 |
| Yaseri, M | 1 |
| Ahmadieh, H | 1 |
1 other study available for fasudil and Anterior Ischemic Optic Neuropathy
| Article | Year |
|---|---|
Intravitreal Injection of a Rho-Kinase Inhibitor (Fasudil) for Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Aged; Female; Humans; Intravitreal Injections; Male; | 2016 |